Changeflow GovPing Healthcare & Life Sciences USPTO Intent to Use Trademark Application for L...
Routine Notice Added Final

USPTO Intent to Use Trademark Application for LYLEQ AX

Favicon for changeflow.com USPTO Trademarks - Pharmaceuticals (Class 005)
Published
Detected
Email

Summary

The USPTO has received an intent-to-use trademark application for the mark LYLEQ AX, filed on November 12, 2025. The application is for oral contraceptives. This filing indicates a future intention to use the mark in commerce.

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

The United States Patent and Trademark Office (USPTO) has recorded an intent-to-use trademark application for the mark LYLEQ AX. The application, identified by serial number 99492404, was filed on November 12, 2025, and pertains to oral contraceptives.

This filing signifies the applicant's intention to use the mark in the future for goods in Class 005. While this is an administrative filing and does not impose immediate compliance obligations, it is a step in the trademark registration process. Companies operating in the pharmaceutical sector should be aware of new trademark filings that may impact their own branding and product strategies.

Archived snapshot

Mar 24, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Trademark Applications

LYLEQ AX

Intent to Use TM99492404 Kind: intenttouse Mar 22, 2026

Abstract

Oral contraceptives

Filing Date

2025-11-12

View original document →

Get daily alerts for USPTO Trademarks - Pharmaceuticals (Class 005)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
November 12th, 2025
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
TM99492404

Who this affects

Applies to
Drug manufacturers Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Drug Labeling
Geographic scope
United States US

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Legal
Topics
Intellectual Property

Get alerts for this source

We'll email you when USPTO Trademarks - Pharmaceuticals (Class 005) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!